NO165917C - Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn.Info
- Publication number
- NO165917C NO165917C NO870128A NO870128A NO165917C NO 165917 C NO165917 C NO 165917C NO 870128 A NO870128 A NO 870128A NO 870128 A NO870128 A NO 870128A NO 165917 C NO165917 C NO 165917C
- Authority
- NO
- Norway
- Prior art keywords
- difluorhex
- preparation
- therapeutic active
- analogy procedure
- active diamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
- C07C211/24—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
- C07C211/23—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton containing carbon-to-carbon triple bonds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/818,848 US4707498A (en) | 1986-01-14 | 1986-01-14 | Fluorinated diaminoalkyne derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO870128D0 NO870128D0 (no) | 1987-01-13 |
| NO870128L NO870128L (no) | 1987-07-15 |
| NO165917B NO165917B (no) | 1991-01-21 |
| NO165917C true NO165917C (no) | 1991-05-02 |
Family
ID=25226588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO870128A NO165917C (no) | 1986-01-14 | 1987-01-13 | Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4707498A (ja) |
| EP (1) | EP0229658B1 (ja) |
| JP (1) | JP2520244B2 (ja) |
| KR (1) | KR900006748B1 (ja) |
| CN (1) | CN1013491B (ja) |
| AR (1) | AR241898A1 (ja) |
| AT (1) | ATE55596T1 (ja) |
| AU (1) | AU589245B2 (ja) |
| CA (1) | CA1269996A (ja) |
| DE (1) | DE3764276D1 (ja) |
| DK (1) | DK14987A (ja) |
| ES (1) | ES2016570B3 (ja) |
| FI (1) | FI85582C (ja) |
| GR (1) | GR3000786T3 (ja) |
| HU (1) | HU199772B (ja) |
| IL (1) | IL81213A (ja) |
| NO (1) | NO165917C (ja) |
| NZ (1) | NZ218890A (ja) |
| PT (1) | PT84100B (ja) |
| ZA (1) | ZA87159B (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085845B2 (ja) * | 1987-05-12 | 1996-01-24 | 住友化学工業株式会社 | エステル化合物およびそれを有効成分とする殺虫剤 |
| IL83086A (en) * | 1987-07-06 | 1991-03-10 | Teva Pharma | Stable,injectable solutions of vincristine salts |
| EP0369944A1 (de) * | 1988-11-18 | 1990-05-23 | Ciba-Geigy Ag | Substituierte Oxadiaminobutane |
| EP0452264A1 (de) * | 1990-04-11 | 1991-10-16 | Ciba-Geigy Ag | Hydroxylamin-Verbindungen |
| IL121789A (en) * | 1996-10-03 | 2001-06-14 | Rohm & Haas | A medicinal product for inhibiting mammalian cell tumors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4139563A (en) * | 1977-07-01 | 1979-02-13 | Merrell Toraude Et Compagnie | α-ACETYLENIC DERIVATIVES OF AMINES |
| US4193563A (en) * | 1977-12-01 | 1980-03-18 | Carmen Vitale | Apparatus for carrying and dispensing cable |
| IE54304B1 (en) * | 1981-08-19 | 1989-08-16 | Merrell Dow France | Fluorinated diamino-heptene and -heptyne derivatives |
| US4421768A (en) * | 1982-08-11 | 1983-12-20 | Merrell Toraude Et Compagnie | Fluorinated diamino-heptene and-heptyne derivatives |
-
1986
- 1986-01-14 US US06/818,848 patent/US4707498A/en not_active Expired - Lifetime
-
1987
- 1987-01-09 AR AR87306437A patent/AR241898A1/es active
- 1987-01-09 ZA ZA87159A patent/ZA87159B/xx unknown
- 1987-01-09 IL IL81213A patent/IL81213A/xx not_active IP Right Cessation
- 1987-01-12 NZ NZ218890A patent/NZ218890A/xx unknown
- 1987-01-12 AU AU67477/87A patent/AU589245B2/en not_active Ceased
- 1987-01-13 CA CA000527188A patent/CA1269996A/en not_active Expired - Fee Related
- 1987-01-13 AT AT87100336T patent/ATE55596T1/de active
- 1987-01-13 EP EP87100336A patent/EP0229658B1/en not_active Expired - Lifetime
- 1987-01-13 CN CN87100255A patent/CN1013491B/zh not_active Expired
- 1987-01-13 DK DK014987A patent/DK14987A/da unknown
- 1987-01-13 HU HU87101A patent/HU199772B/hu not_active IP Right Cessation
- 1987-01-13 DE DE8787100336T patent/DE3764276D1/de not_active Expired - Fee Related
- 1987-01-13 KR KR1019870000188A patent/KR900006748B1/ko not_active IP Right Cessation
- 1987-01-13 ES ES87100336T patent/ES2016570B3/es not_active Expired - Lifetime
- 1987-01-13 PT PT84100A patent/PT84100B/pt unknown
- 1987-01-13 NO NO870128A patent/NO165917C/no unknown
- 1987-01-13 JP JP62004225A patent/JP2520244B2/ja not_active Expired - Fee Related
- 1987-01-14 FI FI870139A patent/FI85582C/fi not_active IP Right Cessation
-
1990
- 1990-09-12 GR GR90400644T patent/GR3000786T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62167744A (ja) | 1987-07-24 |
| GR3000786T3 (en) | 1991-10-10 |
| NO165917B (no) | 1991-01-21 |
| HUT46650A (en) | 1988-11-28 |
| DE3764276D1 (de) | 1990-09-20 |
| CN87100255A (zh) | 1987-09-30 |
| EP0229658A1 (en) | 1987-07-22 |
| NZ218890A (en) | 1989-10-27 |
| FI870139A0 (fi) | 1987-01-14 |
| PT84100A (en) | 1987-02-01 |
| JP2520244B2 (ja) | 1996-07-31 |
| IL81213A (en) | 1990-08-31 |
| ZA87159B (en) | 1987-08-26 |
| CN1013491B (zh) | 1991-08-14 |
| FI870139A (fi) | 1987-07-15 |
| US4707498A (en) | 1987-11-17 |
| ES2016570B3 (es) | 1990-11-16 |
| DK14987D0 (da) | 1987-01-13 |
| AR241898A1 (es) | 1993-01-29 |
| ATE55596T1 (de) | 1990-09-15 |
| KR870007098A (ko) | 1987-08-14 |
| AU6747787A (en) | 1987-07-16 |
| KR900006748B1 (ko) | 1990-09-20 |
| AU589245B2 (en) | 1989-10-05 |
| FI85582C (fi) | 1992-05-11 |
| FI85582B (fi) | 1992-01-31 |
| NO870128L (no) | 1987-07-15 |
| EP0229658B1 (en) | 1990-08-16 |
| HU199772B (en) | 1990-03-28 |
| PT84100B (pt) | 1989-02-28 |
| DK14987A (da) | 1987-07-15 |
| NO870128D0 (no) | 1987-01-13 |
| CA1269996A (en) | 1990-06-05 |
| IL81213A0 (en) | 1987-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO166639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner. | |
| NO871267L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO165344C (no) | Analogifremgangsmaate for fremstilling av teraputisk aktive indolizin-derivater. | |
| NO874869D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO871277D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler. | |
| NO875082L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer. | |
| NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
| NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO166080C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner. | |
| NO871588D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. | |
| NO163184C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater. | |
| NO164168C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser. | |
| NO863671D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. | |
| NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO163486C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater. | |
| NO873108D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner. | |
| NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO165104C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater. | |
| NO873835D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner. | |
| NO881768D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner. | |
| NO165917C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn. |